Familial Pseudo‐Wolff‐Parkinson‐White Syndrome
暂无分享,去创建一个
J. Brugada | R. Brugada | P. Brugada | K. Hong | E. Sternick | A. Oliva | Luiz P. Magalhaes | L. Gerken | O. Santana
[1] G. Taffet,et al. Transgenic Mouse Model of Ventricular Preexcitation and Atrioventricular Reentrant Tachycardia Induced by an AMP-Activated Protein Kinase Loss-of-Function Mutation Responsible for Wolff-Parkinson-White Syndrome , 2005, Circulation.
[2] R. Brugada,et al. [Genetics and arrhythmias]. , 2003, Revista espanola de cardiologia.
[3] J. Seidman,et al. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome. , 2003, Journal of the American College of Cardiology.
[4] Ferhaan Ahmad,et al. Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy , 2003, Circulation.
[5] B. Lerman,et al. Molecular Genetic Analysis of PRKAG2 in Sporadic Wolff‐Parkinson‐White Syndrome , 2003, Journal of cardiovascular electrophysiology.
[6] M. Gollob,et al. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy , 2002, Current opinion in cardiology.
[7] J. Seidman,et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. , 2002, The Journal of clinical investigation.
[8] J. Seger,et al. Novel PRKAG2 Mutation Responsible for the Genetic Syndrome of Ventricular Preexcitation and Conduction System Disease With Childhood Onset and Absence of Cardiac Hypertrophy , 2001, Circulation.
[9] L. Fananapazir,et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. , 2001, The New England journal of medicine.
[10] H. Watkins,et al. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. , 2001, Human molecular genetics.
[11] S. Reed,et al. A multi-epitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in radioimmunoprecipitation-confirmed and consensus-positive sera. , 1999, The Journal of infectious diseases.
[12] S. Donnelly,et al. Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. , 1994, The Journal of clinical investigation.
[13] J. Soni,et al. Syncope in hypertrophic cardiomyopathy. II. Coexistence of atrioventricular block and Wolff-Parkinson-White syndrome. , 1985, American heart journal.
[14] W. M. Smith,et al. Role of Mahaim Fibers in Cardiac Arrhythmias in Man , 1981, Circulation.
[15] J. Gallagher,et al. Characteristics of Atrioventricular Conduction and the Spectrum of Arrhythmias in Lown-Ganong-Levine Syndrome , 1978, Circulation.
[16] M. Brodsky,et al. Familial atrial tachyarrhythmia with short PR interval. , 1977, Archives of internal medicine.
[17] M. Camargo,et al. Hemagglutination with preserved, sensitized cells, a practical test for routine serologic diagnosis of American trypanosomiasis. , 1973, Revista do Instituto de Medicina Tropical de Sao Paulo.
[18] I. Mahaim,et al. Nouvelles recherches sur les connexions supérieures de la branche gauche du faisceau de His-Tawara avec la cloison interventriculaire , 1937 .
[19] H. Wellens,et al. Electrocardiogram in patients with fasciculoventricular pathways: a comparative study with anteroseptal and midseptal accessory pathways. , 2005, Heart rhythm.
[20] S. Gulotta,et al. Familial occurrence of sinus bradycardia, short PR interval, intraventricular conduction defects, recurrent supraventricular tachycardia, and cardiomegaly. , 1977, American heart journal.
[21] H. J. J. W. M. D.,et al. Electrical Stimulation of the Heart in the Study and Treatment of Tachycardias , 1971, Springer Netherlands.